Academic Journal

Phase 1/2a study of the IRAK4 inhibitor CA-4948 as monotherapy or in combination with azacitidine or venetoclax in patients with relapsed/refractory (R/R) acute myeloid leukemia or lyelodysplastic syndrome.

التفاصيل البيبلوغرافية
العنوان: Phase 1/2a study of the IRAK4 inhibitor CA-4948 as monotherapy or in combination with azacitidine or venetoclax in patients with relapsed/refractory (R/R) acute myeloid leukemia or lyelodysplastic syndrome.
المؤلفون: Garcia-Manero, Guillermo, Winer, Eric S., DeAngelo, Daniel J., Tarantolo, Stefano R., Sallman, David Andrew, Dugan, James, Groepper, Stefanie, Giagounidis, Aristoteles, Gotze, Katharina S., Metzeler, Klaus, Li, Chia-Cheng, Zhou, Li, Martinez, Elizabeth, Lane, Maureen E., Von Roemeling, Reinhard W., Bohme, Matthias, Kubasch, Anne Sophie, Verma, Amit K., Platzbecker, Uwe
المساهمون: Klinik und Poliklinik für Innere Medizin III, Hämatologie und Onkologie
سنة النشر: 2022
المجموعة: Munich University of Technology (TUM): mediaTUM
مصطلحات موضوعية: info:eu-repo/classification/ddc
نوع الوثيقة: article in journal/newspaper
اللغة: unknown
Relation: https://mediatum.ub.tum.de/1717499
الاتاحة: https://mediatum.ub.tum.de/1717499
Rights: info:eu-repo/semantics/restrictedAccess
رقم الانضمام: edsbas.84F8723C
قاعدة البيانات: BASE